A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 Virus

被引:33
|
作者
Abed, Yacine
Baz, Mariana
Boivin, Guy [1 ]
机构
[1] CHUQ CHUL, Res Ctr Infect Dis, Ste Foy, PQ G1V 4G2, Canada
来源
JOURNAL OF INFECTIOUS DISEASES | 2009年 / 199卷 / 02期
基金
加拿大健康研究院;
关键词
IMMUNOCOMPROMISED PATIENT; ANTIVIRAL THERAPY; HIGHLY POTENT; IN-VITRO; A VIRUS; INHIBITORS; INFECTIONS;
D O I
10.1086/595736
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neuraminidase (NA) mutations responsible for influenza resistance to oseltamivir vary according to the NA subtype; in influenza A/H3N2 viruses, NA-gene mutations occur predominantly at codons E119 and R292. In an oseltamivir-resistant influenza A/H3N2 virus isolated from an immunocompromised child after 107 days of cumulative treatment, the NA gene contained 3 aa substitutions (N146K, S219T, and A272V) and a 4-aa deletion (Del245-248); reversion mutation experiments using recombinantNAproteins determined that the deletion was the sole change responsible for resistance to oseltamivir. This study highlights the diversity of mechanisms of resistance to oseltamivir in clinical settings, reinforcing the need for novel anti-influenza strategies.
引用
收藏
页码:180 / 183
页数:4
相关论文
共 50 条
  • [2] Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses
    Marjuki, Henju
    Mishin, Vasiliy P.
    Chesnokov, Anton P.
    De La Cruz, Juan A.
    Davis, Charles T.
    Villanuev, Julie M.
    Fry, Alicia M.
    Gubareva, Larisa V.
    JOURNAL OF VIROLOGY, 2015, 89 (10) : 5419 - 5426
  • [3] Multiple Influenza A (H3N2) Mutations Conferring Resistance to Neuraminidase Inhibitors in a Bone Marrow Transplant Recipient
    Eshaghi, Alireza
    Shalhoub, Sarah
    Rosenfeld, Paul
    Li, Aimin
    Higgins, Rachel R.
    Stogios, Peter J.
    Savchenko, Alexei
    Bastien, Nathalie
    Li, Yan
    Rotstein, Coleman
    Gubbaya, Jonathan B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) : 7188 - 7197
  • [4] Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses
    Gulati, Shelly
    Smith, David F.
    Air, Gillian M.
    VIROLOGY JOURNAL, 2009, 6
  • [5] Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses
    Shelly Gulati
    David F Smith
    Gillian M Air
    Virology Journal, 6
  • [6] Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification
    Steain, Megan C.
    Dwyer, Dominic E.
    Hurt, Aeron C.
    Kol, Chenda
    Saksena, Nitin K.
    Cunningham, Anthony L.
    Wang, Bin
    ANTIVIRAL RESEARCH, 2009, 84 (03) : 242 - 248
  • [7] Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation
    Kawai, Naoki
    Ikematsu, Hideyuki
    Iwaki, Norio
    Kondou, Kunio
    Hirotsu, Nobuo
    Kawashima, Takashi
    Maeda, Tetsunari
    Tanaka, Osame
    Doniwa, Ken-ichi
    Kashiwagi, Seizaburo
    JOURNAL OF INFECTION, 2009, 59 (03) : 207 - 212
  • [9] Epitope peptides of influenza H3N2 virus neuraminidase gene designed by immunoinformatics
    Liang, Lijun
    Huang, Ping
    Wen, Miaoheng
    Ni, Hanzhong
    Tan, Songnuan
    Zhang, Yonghui
    Chen, Qiuxia
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2012, 44 (02) : 113 - 118
  • [10] Spread of predominant neuraminidase and hemagglutinin comutations in the influenza A/H3N2 virus genome
    Chong, Yong
    Ikematsu, Hideyuki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (03) : 193 - 198